GT Biopharma, Inc
Fundamentals
Oldest to newest| Line | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating income | −$57.5M | −$21.3M | −$13.6M | −$14.4M | −$12.4M |
| Net income | −$58.0M | −$20.9M | −$7.6M | −$13.2M | −$28.4M |
| Operating cash flow | −$15.6M | −$15.2M | −$8.9M | −$12.9M | −$12.9M |
| Cash | $9.0M | $5.7M | $1.1M | $4.0M | $6.8M |
| Shares outstanding | 32.1M | 1.1M | 1.4M | 2.2M | 25.5M |